Medicine News and Research

RSS

Amifostine makes radiation more effective

Doctors in Brazil have concluded that the drug amifostine eases many of the most common side effects associated with patients receiving radiation therapy to treat their cancer while simultaneously making the cancer more susceptible to radiation.

1 Mar 2006

Delayed surgical treatment may combat overtreatment of prostate cancer

Delayed surgical treatment for patients with small, low-grade prostate cancer tumors was not associated with lowered curability, according to a study in the March 1 issue of the Journal of the National Cancer Institute.

1 Mar 2006

FDA approves Rituxan (Rituximab)

Rituxan is the first treatment for RA that selectively targets immune cells known as CD20-positive B-cells. Through this unique mechanism of action, Rituxan may affect multiple pathways by which B-cells are believed to contribute to the initiation and development of RA.

1 Mar 2006

Ancient DNA helps unearth potential hemophilia therapy

A cut can be life-threatening for people with hemophilia, whose bodies don't produce enough of a protein that prevents prolonged bleeding.

1 Mar 2006

Ethnicity the most important personal characteristic in predicting complementary medicine use

A survey of older adults in rural North Carolina shows that they widely use complementary medicine therapies, but tend to focus on folk or home remedies, such as taking a daily "tonic" of vinegar or using Epsom salts.

1 Mar 2006

Defective apoptosis of dendritic cells can be a critical component of autoimmune diseases

The failure of programming that sparks the death of dendritic cells - those that activate the immune system - can initiate autoimmune disease, said researchers from Baylor College of Medicine in a report that appears in the current issue of the journal Science.

1 Mar 2006

Scientists reprogramme malignant melanoma cells to become normal pigment cells

Scientists at Northwestern University and the Stowers Institute for Medical Research have reprogrammed malignant melanoma cells to become normal melanocytes, or pigment cells, a development that may hold promise in treating of one of the deadliest forms of cancer.

1 Mar 2006

Enhanced external counterpulsation (EECP) reduces angina

Patients with angina (chest pain) and left ventricular dysfunction respond very well to treatment using enhanced external counterpulsation (EECP), with little or no future heart failure events, according to researchers from the Cardiovascular Institute at the University of Pittsburgh Medical Center (UPMC).

1 Mar 2006

Upsurge in diabetes-related deaths in New York City

Researchers at the Albert Einstein College of Medicine of Yeshiva University have documented a dramatic upsurge in diabetes-related deaths and illnesses in New York City - including a sharp increase in diabetic patients hospitalized with heart attacks.

1 Mar 2006

Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer

A new study shows that patients whose colorectal cancer has spread to the liver who received an approach called hepatic arterial infusion (HAI) - the administration of chemotherapy directly to the liver through a pump in the abdomen - fare better than those who received traditional, intravenous chemotherapy.

1 Mar 2006

Can stem cell research lead the way to affordability?

The proliferation of patents in the emerging stem cell field may impede scientists from developing new treatments, says Merrill Goozner of the Center for Science in the Public Interest in the open access journal PLoS Medicine.

1 Mar 2006

The legal and ethical issues associated with human embryonic stem cell research

"As my university gears up for human embryonic stem cell research," says Stanford law professor Henry Greely in an Essay for PLoS Medicine, "it finds that a host of ethical and legal questions still need to be answered."

1 Mar 2006

West Nile virus epidemics in North America are driven by shifts in mosquito feeding behavior

Since its introduction to the United States in 1999, West Nile virus has become the major vector-borne disease in the U.S., with 770 reported deaths, 20,000 reported illnesses, and perhaps around a million people infected.

1 Mar 2006

Celebrex safe for osteoarthritis

According to a study by Stanford University School of Medicine, Celebrex causes fewer gastrointestinal complications than traditional nonsteroidal anti-inflammatory painkillers or NSAIDs in osteoarthritis patients and does not increase the risk of heart attacks.

1 Mar 2006

Why more women die than men after heart bypass surgery

According to researchers, infections - including those acquired in hospitals, could explain why women die more frequently than men after heart bypass surgery and the explanations for this sex difference are controversial.

28 Feb 2006

Eating and drinking Cocoa helps you live longer

According to Dutch researchers, men by eating or drinking cocoa lowered their risk of dying from heart disease by 50 percent compared to those who did not eat cocoa, and also lowered their blood pressure.

28 Feb 2006

Is persistent bacterial infection good for your health?

Bacteria are bad. Mothers and doctors, not to mention the cleaning product industry, repeatedly warn of their dangers. But a Stanford University School of Medicine microbiologist is raising the intriguing idea that persistent bacterial and viral infections have benefits.

27 Feb 2006

Analysis of protein interactions dispels old notions of what's important about them

Discoveries made during the first large-scale analysis of interactions between proteins in our cells hold promise for identifying new genes involved in genetic diseases, according to researchers at Johns Hopkins and the Institute of Bioinformatics (IOB) in Bangalore.

27 Feb 2006